Against the backdrop of high medical costs and an imbalance of access to care, is there reason to be optimistic about the ...

Lab-developed tests look likely to be removed from FDA oversight. That has to change, writes Walter G. Johnson.

and expert opinions related to the medical records are obtained. Hospitals and insurance companies know that 99% of people ...